Intrinsic Edge Capital Management LLC bought a new position in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 10,000 shares of the semiconductor company’s stock, valued at approximately $4,934,000.
Several other institutional investors and hedge funds have also bought and sold shares of SNPS. Stanley Laman Group Ltd. boosted its holdings in Synopsys by 542.9% in the third quarter. Stanley Laman Group Ltd. now owns 12,877 shares of the semiconductor company’s stock valued at $6,353,000 after acquiring an additional 10,874 shares in the last quarter. Symphony Financial Ltd. Co. raised its holdings in Synopsys by 4,780.9% in the 2nd quarter. Symphony Financial Ltd. Co. now owns 40,219 shares of the semiconductor company’s stock worth $20,638,000 after purchasing an additional 39,395 shares in the last quarter. Bank of New York Mellon Corp lifted its position in shares of Synopsys by 0.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 1,347,887 shares of the semiconductor company’s stock worth $691,035,000 after purchasing an additional 4,815 shares during the period. Empirical Asset Management LLC purchased a new stake in shares of Synopsys in the 3rd quarter worth about $773,000. Finally, Waverton Investment Management Ltd boosted its stake in shares of Synopsys by 15.0% during the 2nd quarter. Waverton Investment Management Ltd now owns 578,299 shares of the semiconductor company’s stock valued at $296,630,000 after purchasing an additional 75,374 shares in the last quarter. 85.47% of the stock is currently owned by hedge funds and other institutional investors.
Insider Transactions at Synopsys
In other Synopsys news, CFO Shelagh Glaser sold 3,657 shares of Synopsys stock in a transaction dated Friday, December 19th. The shares were sold at an average price of $460.77, for a total value of $1,685,035.89. Following the completion of the transaction, the chief financial officer directly owned 17,842 shares of the company’s stock, valued at approximately $8,221,058.34. The trade was a 17.01% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Janet Lee sold 250 shares of the company’s stock in a transaction that occurred on Monday, January 12th. The stock was sold at an average price of $530.00, for a total transaction of $132,500.00. Following the completion of the transaction, the insider owned 11,959 shares in the company, valued at approximately $6,338,270. This represents a 2.05% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 4,157 shares of company stock valued at $1,945,036. 0.56% of the stock is owned by company insiders.
Synopsys Stock Down 0.1%
Synopsys (NASDAQ:SNPS – Get Free Report) last released its earnings results on Wednesday, February 25th. The semiconductor company reported $3.77 EPS for the quarter, topping analysts’ consensus estimates of $3.56 by $0.21. The firm had revenue of $2.41 billion for the quarter, compared to analysts’ expectations of $2.39 billion. Synopsys had a return on equity of 6.83% and a net margin of 13.76%.The company’s quarterly revenue was up 65.6% on a year-over-year basis. During the same period in the prior year, the firm posted $3.03 earnings per share. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. On average, research analysts anticipate that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.
Analysts Set New Price Targets
Several brokerages have commented on SNPS. The Goldman Sachs Group set a $600.00 price objective on shares of Synopsys and gave the stock a “buy” rating in a report on Wednesday, February 25th. Piper Sandler lowered their target price on Synopsys from $520.00 to $430.00 and set a “neutral” rating for the company in a research note on Thursday, February 26th. Wells Fargo & Company dropped their price target on Synopsys from $500.00 to $450.00 and set an “equal weight” rating on the stock in a research report on Thursday, February 26th. KeyCorp increased their price objective on Synopsys from $575.00 to $600.00 and gave the stock an “overweight” rating in a report on Thursday, December 11th. Finally, Citigroup assumed coverage on shares of Synopsys in a report on Monday, November 24th. They set a “buy” rating and a $580.00 target price on the stock. Eight analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $531.00.
Get Our Latest Analysis on Synopsys
Synopsys Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Read More
- Five stocks we like better than Synopsys
- New Copper-Rich “Kraken” Zone Discovered
- America’s 1776 happening again
- 3 Signs You May Want to Switch Financial Advisors
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
- Silver’s squeeze is tightening – opportunity forming
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
